Hydrochlorides
Medchemexpress LLC EG01377 dihydrochloride | 2749438-61-5 | 99.0% | 659.60 | 1 MG
EG01377 dihydrochloride | 2749438-61-5 | 99.0% | 659.60 | 1 MG
Sigma Aldrich Fine Chemicals Biosciences o-Phenylenediamine dihydrochloride tablet, 4 mg substrate per tablet | 615-28-1 | MFCD00012966 | 50TAB
o-Phenylenediamine dihydrochloride tablet, 4 mg substrate per tablet | Mol Wt: 181.06 | 615-28-1 | MFCD00012966 | 50TAB
Apexbio Technology LLC Tirofiban 144494-65-5 5mg
Tirofiban is a selective non-peptide antagonist targeting platelet glycoprotein (GP) IIb/IIIa receptors a heterodimeric complex abundantly expressed on platelet surfaces responsible for mediating fibrinogen binding and platelet aggregation It acts through competitive inhibition of fibrinogen binding at GP IIb/IIIa sites thereby suppressing platelet cross-linking and aggregation induced by agonists like ADP In vitro studies demonstrate that Tirofiban inhibits ADP-induced platelet aggregation with an IC50 value of approximately 9 nM showing significantly lower affinity for integrin v 3 (vitronectin receptor) Tirofiban is frequently applied in biomedical research investigating platelet aggregation mechanisms and thrombotic events
eMolecules 89990-54-5 | Pyrazolidine dihydrochloride | ChemScene | MFCD16620353 | 145.030 | C3H10Cl2N2 | 95.000 | Cl.Cl.C1CNNC1 | 1g | 654759654
Pyrazolidine dihydrochloride | ChemScene | 89990-54-5 | MFCD16620353 | 145.030 | C3H10Cl2N2 | 95.000 | Cl.Cl.C1CNNC1 | 1g | 654759654
eMolecules 89990-54-5 | Pyrazolidine dihydrochloride | Combi-Blocks | MFCD16620353 | 145.030 | C3H10Cl2N2 | 96.000 | Cl.Cl.C1CNNC1 | 5g | 457917117
Pyrazolidine dihydrochloride | Combi-Blocks | 89990-54-5 | MFCD16620353 | 145.030 | C3H10Cl2N2 | 96.000 | Cl.Cl.C1CNNC1 | 5g | 457917117
Medchemexpress LLC Roxindole hydrochloride | 108050-82-4 | 99.0% | 382.93 g/mol | C23H27ClN2O | 1 ML
Roxindole hydrochloride is a research chemical acting as a dopamine autoreceptor agonist and a 5-HT1A receptor agonist with reported antipsychotic and antidepressant activity. It is intended for laboratory research and analytical use and is supplied in solution and solid forms with accompanying documentation for traceability and safety.
Medchemexpress LLC Idazoxan hydrochloride | 79944-56-2 | MFCD00069293 | 99.32% | C11H13ClN2O2 | 1 ML
Idazoxan hydrochloride is a compound that acts as an α2-adrenoceptor antagonist and an imidazoline receptors antagonist. It is known for its ability to competitively antagonize the centrally induced hypotensive effect of imidazoline-like agents. Research indicates its potential to improve motor symptoms associated with Parkinson's disease, L-DOPA-induced dyskinesias, and experimental Parkinsonism.
- Acts as an α2-adrenoceptor antagonist
- Functions as an imidazoline receptors antagonist
- Competitively antagonizes centrally induced hypotensive effects
- Potential to improve motor symptoms in Parkinson's disease
- Potential to improve L-DOPA-induced dyskinesias
- Potential to improve experimental Parkinsonism
- Reverses haloperidol-induced catalepsy in rat models
Medchemexpress LLC SB 206553 hydrochloride | 1197334-04-5 | 99.4% | 328.80 g·mol⁻1 | C17H17ClN4O | 5 MG
SB 206553 hydrochloride is the hydrochloride salt of SB 206553, a selective, orally active antagonist of serotonin 5-HT2B and 5-HT2C receptors used in preclinical receptor pharmacology and behavioral studies.
- High-affinity 5-HT2B/5-HT2C receptor antagonist.
- Hydrochloride salt form for improved solubility.
- High purity suitable for research (99.4%).
- Available in small research quantities, such as 5 mg.
Medchemexpress LLC ADL-5859 hydrochloride | 850173-95-4 | 99.0% | 1 ML
ADL-5859 hydrochloride (compound 20) is a selective and orally active δ opioid receptor (DOR) agonist with a Ki of 0.84 nM and an EC50 value of 20 nM. It also exhibits inhibitory activity to the hERG channel with an IC50 value of 78 μM. ADL-5859 hydrochloride can be utilized for pain research.
- Selective and orally active δ opioid receptor agonist
- Ki of 0.84 nM
- EC50 value of 20 nM
- Inhibitory activity to the hERG channel with an IC50 value of 78 μM
- Useful for pain research
Medchemexpress LLC TG 100572 hydrochloride | 867331-64-4 | 98.8% | 512.43 g/mol | C26H27Cl2N5O2 | 1 ML
TG 100572 Hydrochloride is the hydrochloride salt of a multi-targeted kinase inhibitor that blocks selected receptor tyrosine kinases and Src family kinases. It is provided for research use in biochemical and cell-based studies and is available as a ready-to-use solution or as a solid form.
- Multi-targeted kinase inhibitor active against receptor tyrosine kinases and Src family kinases.
- Supplied as a 10 mM solution in DMSO (1 mL) for immediate use.
- Also available as a solid with a pink to red appearance.
- High purity (~98.8%) suitable for research applications.
- Store sealed, away from moisture; in solvent store at -80°C for up to 6 months.
Medchemexpress LLC YNT-185 dihydrochloride | 1804978-82-2 | 99.8% | 688.66 | 25 MG
YNT-185 dihydrochloride is a nonpeptide, selective orexin type-2 receptor (OX2R) agonist. It demonstrates high selectivity with EC50s of 0.028 μM for OX2R and 2.75 μM for OX1R. This compound has been shown to ameliorate narcolepsy-cataplexy symptoms in mouse models, increasing wakefulness and decreasing NREM sleep time.
- Selective orexin type-2 receptor (OX2R) agonist
- Nonpeptide compound
- EC50 of 0.028 μM for OX2R
- Ameliorates narcolepsy-cataplexy symptoms in mouse models
- Increases wakefulness
- Decreases NREM sleep time
eMolecules 19524-06-2 | 4-Bromopyridine hydrochloride | Combi-Blocks | MFCD00012828 | 194.460 | C5H5BrClN | 98.000 | Cl.Brc1ccncc1 | 5g | 117556755
4-Bromopyridine hydrochloride | Combi-Blocks | 19524-06-2 | MFCD00012828 | 194.460 | C5H5BrClN | 98.000 | Cl.Brc1ccncc1 | 5g | 117556755
Medchemexpress LLC Duloxetine metabolite Para-Naphthol Duloxetine | 949095-98-1 | 297.41 | 50 MG
Duloxetine metabolite Para-Naphthol Duloxetine is a metabolite of Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI). This product is intended for research use only and is not sold to patients.
- Metabolite of Duloxetine
- For research use only
- Molecular formula: C18H19NOS
- Appearance: Solid
- Color: White to off-white
- Store powder at -20°C for 3 years
- Store in solvent at -80°C for 6 months, or -20°C for 1 month
Medchemexpress LLC Sb-258585 hydrochloride | 1216468-02-8 | 99.7% | 523.82 g·mol⁻¹ | C18H23ClIN3O3S | 5 MG
SB-258585 hydrochloride is the hydrochloride salt of a selective, high-affinity antagonist for the serotonin 5-HT6 receptor. Supplied as a research-grade powder, it is intended for in vitro receptor binding and pharmacology studies and is characterized by high purity and defined storage conditions.
- Selective 5-HT6 receptor antagonist with high affinity.
- Suitable for in vitro receptor binding and pharmacological assays.
- Provided as a hydrochloride salt in powder form for accurate dosing.
- High purity (>99.7%) for reproducible results.
- Stable when stored under recommended conditions (powder: -20°C).
Medchemexpress LLC Ipn60090 dihydrochloride | 2102101-72-2 | 99.7% | 605.44 g/mol | C24H29Cl2F3N8O3 | 1 ML
IPN60090 dihydrochloride is a potent, selective small-molecule inhibitor of glutaminase 1 (GLS1), provided as a dihydrochloride salt for preclinical research. It is offered as a ready-to-use 10 mM solution in DMSO (1 mL) or as solid samples, with reported high purity and documented in vitro and in vivo activity supporting use in solid tumor studies.
- Highly selective GLS1 inhibitor with reported IC50 = 31 nM.
- Inhibits A549 cell proliferation (IC50 = 26 nM).
- Available as 10 mM solution in DMSO (1 mL) or multiple solid sizes for experimental flexibility.
- High purity suitable for biochemical and cell-based assays.
- Documented pharmacokinetic and efficacy data in preclinical models.